Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Onto Innovation (ONTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Onto Innovation — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.18 (market cap $6.04B), while Onto Innovation trades at $292.19 (market cap $14.36B). The key difference: Onto Innovation is far larger — about 2.4× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Onto Innovation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Onto Innovation for 5 Days on average.
| IOVA | ONTO | |
|---|---|---|
Market Cap | $6.04B | $14.36B |
Volume | 14,805,993 | 761,617 |
Sector | Health | Technology |
52-Week High | $14.82 | $378.45 |
52-Week Low | $1.81 | $121.34 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $5.97B | $13.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →
